Carib A. Oquendo

Array ( [id] => 10813750 [patent_doc_number] => 20160159911 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2016-06-09 [patent_title] => 'ANTI-cMET ANTIBODY' [patent_app_type] => utility [patent_app_number] => 14/248741 [patent_app_country] => US [patent_app_date] => 2014-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 25218 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14248741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10813750 [patent_doc_number] => 20160159911 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2016-06-09 [patent_title] => 'ANTI-cMET ANTIBODY' [patent_app_type] => utility [patent_app_number] => 14/248741 [patent_app_country] => US [patent_app_date] => 2014-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 25218 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14248741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912233 [patent_doc_number] => 20140315250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'HUMANIZED ANTIBODIES AGAINST TL1A' [patent_app_type] => utility [patent_app_number] => 14/244603 [patent_app_country] => US [patent_app_date] => 2014-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8028 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14244603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9656174 [patent_doc_number] => 20140227179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'ANTI-MUCIN ANTIBODIES FOR EARLY DETECTION AND TREATMENT OF PANCREATIC CANCER' [patent_app_type] => utility [patent_app_number] => 14/242138 [patent_app_country] => US [patent_app_date] => 2014-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 61238 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14242138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10678075 [patent_doc_number] => 20160024219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'ANTI-CD52 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/774911 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 21770 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122060 [patent_doc_number] => 20160319034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'MET-BINDING AGENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/776262 [patent_app_country] => US [patent_app_date] => 2014-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 52482 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750394 [patent_doc_number] => 09708396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Bispecific anti-VEGF/anti-ANG-2 antibodies' [patent_app_type] => utility [patent_app_number] => 14/192213 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 37044 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14192213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662321 [patent_doc_number] => 20160008466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'PARTICLE COMPOSITIONS AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 14/768335 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14976 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771146 [patent_doc_number] => 20140294810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'IMMUNOGLOBULIN VARIANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/188432 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 54869 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14188432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9560684 [patent_doc_number] => 20140178397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'ANTI-ANGIOGENIC THERAPY' [patent_app_type] => utility [patent_app_number] => 14/170997 [patent_app_country] => US [patent_app_date] => 2014-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14798 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14170997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9490601 [patent_doc_number] => 20140141007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'STABLE HIGH PROTEIN CONCENTRATION FORMULATIONS OF HUMAN ANTI-TNF-ALPHA-ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/170026 [patent_app_country] => US [patent_app_date] => 2014-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30829 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14170026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9490603 [patent_doc_number] => 20140141008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'STABLE HIGH PROTEIN CONCENTRATION FORMULATIONS OF HUMAN ANTI-TNF-ALPHA-ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/170061 [patent_app_country] => US [patent_app_date] => 2014-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 31266 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14170061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9560618 [patent_doc_number] => 20140178332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'IL-12/p40 BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/154076 [patent_app_country] => US [patent_app_date] => 2014-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50858 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14154076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9462756 [patent_doc_number] => 20140127183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/152544 [patent_app_country] => US [patent_app_date] => 2014-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 20834 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805243 [patent_doc_number] => 20150017188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/152287 [patent_app_country] => US [patent_app_date] => 2014-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 47137 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15634455 [patent_doc_number] => 10590206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Inert format [patent_app_type] => utility [patent_app_number] => 14/760157 [patent_app_country] => US [patent_app_date] => 2014-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 49 [patent_no_of_words] => 27761 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12305934 [patent_doc_number] => 09938344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-10 [patent_title] => Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer [patent_app_type] => utility [patent_app_number] => 14/655982 [patent_app_country] => US [patent_app_date] => 2013-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 44385 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11357413 [patent_doc_number] => 09534055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders' [patent_app_type] => utility [patent_app_number] => 14/102833 [patent_app_country] => US [patent_app_date] => 2013-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 109769 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14102833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11486231 [patent_doc_number] => 09592293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-14 [patent_title] => 'Interleukin-13 binding proteins' [patent_app_type] => utility [patent_app_number] => 14/101145 [patent_app_country] => US [patent_app_date] => 2013-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52405 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14101145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095895 [patent_doc_number] => 09132190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Therapeutic DLL4 binding proteins' [patent_app_type] => utility [patent_app_number] => 14/090778 [patent_app_country] => US [patent_app_date] => 2013-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57481 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1439 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090778 [rel_patent_id] =>[rel_patent_doc_number] =>)